According to a study conducted by the National Institute of Neurological Disorders and Stroke, and published today in the journal Neurology, regular users of ibuprofen have a 40% lower chance of developing Parkinson’s disease than others.
The study also found that people who consume large amounts of ibuprofen are less likely to develop Parkinson’s disease than people who consume little.
The study was carried out on 136,474 people who did not have Parkinson’s disease. The researchers established lists for each participant indicating whether or not they were taking anti-inflammatory drugs (aspirin, ibuprofen, or paracetamol). After six years, 293 of the participants developed Parkinson’s disease.
“Ibuprofen is the only anti-inflammatory that has had a positive impact on Parkinson’s disease. Other anti-inflammatory drugs have had no influence on the disease. More research is needed to understand why and how ibuprofen may have an effect on this disease “, explains Doctor Xiang Gao.
